Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

New insights into apoptosis signaling by Apo2L/TRAIL

Oncogene volume 29, pages 4752–4765 (2010)Cite this article

Subjects

Abstract

Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-α, can activate the extrinsic apoptotic cell death pathway on binding to cognate death receptors at the cell surface. Over the past 10 years, Apo2L/TRAIL has emerged as a promising candidate for cancer therapy, on the basis of its unique ability to trigger apoptosis in various types of cancer cells without significant toxicity toward normal cells. Herein, we review key advances in understanding the molecular events that control apoptosis signaling by Apo2L/TRAIL, which may aid in the development of cancer therapies based on the extrinsic apoptotic pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Akazawa Y, Mott JL, Bronk SF, Werneburg NW, Kahraman A, Guicciardi ME et al. (2009). Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology 136: 2365–2376 e1-7.

    PubMed  Google Scholar 

  • Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL et al. (2003). Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 100: 11445–11450.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Almasan A, Ashkenazi A . (2003). Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14: 337–348.

    CAS  PubMed  Google Scholar 

  • Ashkenazi A . (2002). Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2: 420–430.

    CAS  PubMed  Google Scholar 

  • Ashkenazi A, Dixit VM . (1998). Death receptors: signaling and modulation. Science 281: 1305–1308.

    CAS  PubMed  Google Scholar 

  • Ashkenazi A, Holland P, Eckhardt SG . (2008). Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 26: 3621–3630.

    CAS  PubMed  Google Scholar 

  • Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA et al. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155–162.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Austin CD, Lawrence DA, Peden AA, Varfolomeev EE, Totpal K, De Maziere AM et al. (2006). Death-receptor activation halts clathrin-dependent endocytosis. Proc Natl Acad Sci USA 103: 10283–10288.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Barnhart BC, Alappat EC, Peter ME . (2003). The CD95 type I/type II model. Semin Immunol 15: 185–193.

    CAS  PubMed  Google Scholar 

  • Beraza N, Malato Y, Sander LE, Al-Masaoudi M, Freimuth J, Riethmacher D et al. (2009). Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage. J Exp Med 206: 1727–1737.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM et al. (2003). A unified model for apical caspase activation. Mol Cell 11: 529–541.

    CAS  PubMed  Google Scholar 

  • Bodmer JL, Meier P, Tschopp J, Schneider P . (2000). Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL. J Biol Chem 275: 20632–20637.

    CAS  PubMed  Google Scholar 

  • Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005–1009.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bouchier-Hayes L, Oberst A, McStay GP, Connell S, Tait SW, Dillon CP et al. (2009). Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell 35: 830–840.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Casella CR, Finkel TH . (1997). Mechanisms of lymphocyte killing by HIV. Curr Opin Hematol 4: 24–31.

    CAS  PubMed  Google Scholar 

  • Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC et al. (1999). 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11: 253–261.

    CAS  PubMed  Google Scholar 

  • Chaigne-Delalande B, Mahfouf W, Daburon S, Moreau JF, Legembre P . (2009). CD95 engagement mediates actin-independent and -dependent apoptotic signals. Cell Death Differ 16: 1654–1664.

    CAS  PubMed  Google Scholar 

  • Chakrabandhu K, Herincs Z, Huault S, Dost B, Peng L, Conchonaud F et al. (2007). Palmitoylation is required for efficient Fas cell death signaling. EMBO J 26: 209–220.

    CAS  PubMed  Google Scholar 

  • Chan FK . (2007). Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 37: 101–107.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ . (2000). A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288: 2351–2354.

    CAS  PubMed  Google Scholar 

  • Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S et al. (2002). c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 21: 3704–3714.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L . (1997). Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7: 821–830.

    CAS  PubMed  Google Scholar 

  • Chen M, Orozco A, Spencer DM, Wang J . (2002). Activation of initiator caspases through a stable dimeric intermediate. J Biol Chem 277: 50761–50767.

    CAS  PubMed  Google Scholar 

  • Chen X, Kandasamy K, Srivastava RK . (2003). Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res 63: 1059–1066.

    CAS  PubMed  Google Scholar 

  • Chowdhury I, Tharakan B, Bhat GK . (2006). Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 11: 506–525.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Clancy L, Mruk K, Archer K, Woelfel M, Mongkolsapaya J, Screaton G et al. (2005). Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci USA 102: 18099–18104.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cretney E, McQualter JL, Kayagaki N, Yagita H, Bernard CC, Grewal IS et al. (2005). TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 83: 511–519.

    CAS  PubMed  Google Scholar 

  • Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ . (2002). Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 168: 1356–1361.

    CAS  PubMed  Google Scholar 

  • Danial NN, Korsmeyer SJ . (2004). Cell death: critical control points. Cell 116: 205–219.

    CAS  PubMed  Google Scholar 

  • Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF et al. (1997). Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186: 1165–1170.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Deng Y, Lin Y, Wu X . (2002). TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16: 33–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM et al. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17: 2215–2223.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA et al. (2004). TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21: 877–889.

    CAS  PubMed  Google Scholar 

  • Dumitru CA, Carpinteiro A, Trarbach T, Hengge UR, Gulbins E . (2007). Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis 12: 1533–1541.

    CAS  PubMed  Google Scholar 

  • Eckelman BP, Salvesen GS, Scott FL . (2006). Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988–994.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM, Jeremias I . (2003). TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene 22: 3842–3852.

    CAS  PubMed  Google Scholar 

  • Eimon PM, Kratz E, Varfolomeev E, Hymowitz SG, Stern H, Zha J et al. (2006). Delineation of the cell-extrinsic apoptosis pathway in the zebrafish. Cell Death Differ 13: 1619–1630.

    CAS  PubMed  Google Scholar 

  • Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Fujimura T et al. (2001). Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway. Int J Oncol 18: 311–316.

    CAS  PubMed  Google Scholar 

  • Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C et al. (1998). Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273: 14363–14367.

    CAS  PubMed  Google Scholar 

  • Esposti MD, Erler JT, Hickman JA, Dive C . (2001). Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol Cell Biol 21: 7268–7276.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fadeel B, Orrenius S, Zhivotovsky B . (1999). Apoptosis in human disease: a new skin for the old ceremony? Biochem Biophys Res Commun 266: 699–717.

    CAS  PubMed  Google Scholar 

  • Feig C, Tchikov V, Schutze S, Peter ME . (2007). Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J 26: 221–231.

    CAS  PubMed  Google Scholar 

  • Finnberg N, Klein-Szanto AJ, El-Deiry WS . (2008). TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. J Clin Invest 118: 111–123.

    CAS  PubMed  Google Scholar 

  • Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM et al. (2001). Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 7: 1688–1697.

    CAS  PubMed  Google Scholar 

  • Fulda S, Meyer E, Debatin KM . (2002). Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21: 2283–2294.

    CAS  PubMed  Google Scholar 

  • Gonzalvez F, Bessoule JJ, Rocchiccioli F, Manon S, Petit PX . (2005a). Role of cardiolipin on tBid and tBid/Bax synergistic effects on yeast mitochondria. Cell Death Differ 12: 659–667.

    CAS  PubMed  Google Scholar 

  • Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M, Antonsson B et al. (2005b). tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ 12: 614–626.

    CAS  PubMed  Google Scholar 

  • Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ et al. (2008). Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183: 681–696.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Grassme H, Cremesti A, Kolesnick R, Gulbins E . (2003). Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22: 5457–5470.

    CAS  PubMed  Google Scholar 

  • Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K et al. (2001). CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 276: 20589–20596.

    CAS  PubMed  Google Scholar 

  • Green DR, Amarante-Mendes GP . (1998). The point of no return: mitochondria, caspases, and the commitment to cell death. Results Probl Cell Differ 24: 45–61.

    CAS  PubMed  Google Scholar 

  • Green DR, Reed JC . (1998). Mitochondria and apoptosis. Science 281: 1309–1312.

    CAS  PubMed  Google Scholar 

  • Grinberg M, Sarig R, Zaltsman Y, Frumkin D, Grammatikakis N, Reuveny E et al. (2002). tBID Homooligomerizes in the mitochondrial membrane to induce apoptosis. J Biol Chem 277: 12237–12245.

    CAS  PubMed  Google Scholar 

  • Grosse-Wilde A, Voloshanenko O, Bailey SL, Longton GM, Schaefer U, Csernok AI et al. (2008). TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 118: 100–110.

    CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell 100: 57–70.

    CAS  PubMed  Google Scholar 

  • Hayakawa K, Takemura G, Koda M, Kawase Y, Maruyama R, Li Y et al. (2002). Sensitivity to apoptosis signal, clearance rate, and ultrastructure of fas ligand-induced apoptosis in in vivo adult cardiac cells. Circulation 105: 3039–3045.

    CAS  PubMed  Google Scholar 

  • Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y . (2001). Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 166: 1314–1319.

    CAS  PubMed  Google Scholar 

  • Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E et al. (2000). Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene 19: 5477–5486.

    CAS  PubMed  Google Scholar 

  • Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M . (2009). Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 35: 265–279.

    CAS  PubMed  Google Scholar 

  • Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF et al. (1999). Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4: 563–571.

    CAS  PubMed  Google Scholar 

  • Hymowitz SG, O'Connell MP, Ultsch MH, Hurst A, Totpal K, Ashkenazi A et al. (2000). A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39: 633–640.

    CAS  PubMed  Google Scholar 

  • Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195.

    CAS  PubMed  Google Scholar 

  • Ishimura N, Isomoto H, Bronk SF, Gores GJ . (2006). Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 290: G129–G136.

    CAS  PubMed  Google Scholar 

  • Jin Z, El-Deiry WS . (2006). Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Mol Cell Biol 26: 8136–8148.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR et al. (2009). Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137: 721–735.

    CAS  PubMed  Google Scholar 

  • Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC et al. (2009). XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460: 1035–1039.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A . (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611–620.

    CAS  PubMed  Google Scholar 

  • Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P et al. (2001). Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276: 46639–46646.

    CAS  PubMed  Google Scholar 

  • Kohlhaas SL, Craxton A, Sun XM, Pinkoski MJ, Cohen GM . (2007). Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem 282: 12831–12841.

    CAS  PubMed  Google Scholar 

  • Krammer PH . (2000). CD95's deadly mission in the immune system. Nature 407: 789–795.

    CAS  PubMed  Google Scholar 

  • Kroemer G, Dalaporta B, Resche-Rigon M . (1998). The mitochondria death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619–642.

    CAS  PubMed  Google Scholar 

  • Krueger A, Baumann S, Krammer PH, Kirchhoff S . (2001). FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 21: 8247–8254.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Labrinidis A, Liapis V, Thai le M, Atkins GJ, Vincent C, Hay S et al. (2008). Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis? Blood 111: 5411–5412; autor reply 5413.

    CAS  PubMed  Google Scholar 

  • Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T et al. (1996). Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2: 80–86.

    CAS  PubMed  Google Scholar 

  • Laguinge LM, Samara RN, Wang W, El-Deiry WS, Corner G, Augenlicht L et al. (2008). DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res 68: 909–917.

    CAS  PubMed  Google Scholar 

  • Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH . (2003). Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice. Nat Immunol 4: 255–260.

    CAS  PubMed  Google Scholar 

  • Lavrik I, Golks A, Krammer PH . (2005a). Death receptor signaling. J Cell Sci 118: 265–267.

    CAS  PubMed  Google Scholar 

  • Lavrik IN, Golks A, Krammer PH . (2005b). Caspases: pharmacological manipulation of cell death. J Clin Invest 115: 2665–2672.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B et al. (2001). Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7: 383–385.

    CAS  PubMed  Google Scholar 

  • Le Roy C, Wrana JL . (2005). Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6: 112–126.

    CAS  PubMed  Google Scholar 

  • LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P et al. (2002). Tumor-cell resistance to death receptor—induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 8: 274–281.

    CAS  PubMed  Google Scholar 

  • LeBlanc HN, Ashkenazi A . (2003). Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10: 66–75.

    CAS  PubMed  Google Scholar 

  • Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S et al. (2006). The role of receptor internalization in CD95 signaling. EMBO J 25: 1009–1023.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY et al. (1999). Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 59: 5683–5686.

    CAS  PubMed  Google Scholar 

  • Li H, Zhu H, Xu CJ, Yuan J . (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501.

    CAS  PubMed  Google Scholar 

  • Li J, Yuan J . (2008). Caspases in apoptosis and beyond. Oncogene 27: 6194–6206.

    CAS  PubMed  Google Scholar 

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489.

    CAS  PubMed  Google Scholar 

  • Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S et al. (2000). The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol 20: 6638–6645.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA et al. (2000). The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6: 1389–1399.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lluis JM, Nachbur U, Cook WD, Gentle IE, Moujalled D, Moulin M et al. (2010). TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL. PLoS One 5: e8620.

    PubMed  PubMed Central  Google Scholar 

  • Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M . (2005). Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 64: 854–858.

    CAS  PubMed  Google Scholar 

  • Luo JL, Maeda S, Hsu LC, Yagita H, Karin M . (2004). Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 6: 297–305.

    CAS  PubMed  Google Scholar 

  • Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . (1998). Bid, a bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface receptors. Cell 94: 481–490.

    CAS  PubMed  Google Scholar 

  • Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X . (2000). Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2: 754–761.

    CAS  PubMed  Google Scholar 

  • Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D et al. (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 7: 1003–1006.

    CAS  PubMed  Google Scholar 

  • Martin S, Phillips DC, Szekely-Szucs K, Elghazi L, Desmots F, Houghton JA . (2005). Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Cancer Res 65: 11447–11458.

    CAS  PubMed  Google Scholar 

  • McKenzie M, Liolitsa D, Hanna MG . (2004). Mitochondrial disease: mutations and mechanisms. Neurochem Res 29: 589–600.

    CAS  PubMed  Google Scholar 

  • Meier P, Finch A, Evan G . (2000). Apoptosis in development. Nature 407: 796–801.

    CAS  PubMed  Google Scholar 

  • Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW et al. (2002). The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 277: 45162–45171.

    CAS  PubMed  Google Scholar 

  • Mongkolsapaya J, Grimes JM, Chen N, Xu XN, Stuart DI, Jones EY et al. (1999). Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol 6: 1048–1053.

    CAS  PubMed  Google Scholar 

  • Moscat J, Diaz-Meco MT, Wooten MW . (2007). Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci 32: 95–100.

    CAS  PubMed  Google Scholar 

  • Nagata S . (1997). Apoptosis by death factor. Cell 88: 355–365.

    CAS  PubMed  Google Scholar 

  • Newsom-Davis T, Prieske S, Walczak H . (2009). Is TRAIL the holy grail of cancer therapy? Apoptosis 14: 607–623.

    CAS  PubMed  Google Scholar 

  • Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M . (2009). APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457: 981–989.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nuutinen U, Simelius N, Ropponen A, Eeva J, Matto M, Eray M et al. (2009). PDTC enables type I TRAIL signaling in type II follicular lymphoma cells. Leuk Res 33: 829–836.

    CAS  PubMed  Google Scholar 

  • Opferman JT, Korsmeyer SJ . (2003). Apoptosis in the development and maintenance of the immune system. Nat Immunol 4: 410–415.

    CAS  PubMed  Google Scholar 

  • Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C et al. (2005). Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Hum Immunol 66: 799–809.

    CAS  PubMed  Google Scholar 

  • Ozoren N, El-Deiry WS . (2002). Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Neoplasia 4: 551–557.

    PubMed  PubMed Central  Google Scholar 

  • Ozoren N, Kim K, Burns TF, Dicker DT, Moscioni AD, El-Deiry WS . (2000). The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 60: 6259–6265.

    CAS  PubMed  Google Scholar 

  • Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM . (1997). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815–818.

    CAS  PubMed  Google Scholar 

  • Papoff G, Hausler P, Eramo A, Pagano MG, Di Leve G, Signore A et al. (1999). Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J Biol Chem 274: 38241–38250.

    CAS  PubMed  Google Scholar 

  • Peter ME, Krammer PH . (2003). The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26–35.

    CAS  PubMed  Google Scholar 

  • Petros AM, Olejniczak ET, Fesik SW . (2004). Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644: 83–94.

    CAS  PubMed  Google Scholar 

  • Pickart CM . (2004). Back to the future with ubiquitin. Cell 116: 181–190.

    CAS  PubMed  Google Scholar 

  • Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A . (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687–12690.

    CAS  PubMed  Google Scholar 

  • Prasad KV, Prabhakar BS . (2003). Apoptosis and autoimmune disorders. Autoimmunity 36: 323–330.

    CAS  PubMed  Google Scholar 

  • Prunell GF, Arboleda VA, Troy CM . (2005). Caspase function in neuronal death: delineation of the role of caspases in ischemia. Curr Drug Targets CNS Neurol Disord 4: 51–61.

    CAS  PubMed  Google Scholar 

  • Rodriguez J, Lazebnik Y . (1999). Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 13: 3179–3184.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rohn TT, Head E, Nesse WH, Cotman CW, Cribbs DH . (2001). Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol Dis 8: 1006–1016.

    CAS  PubMed  Google Scholar 

  • Rossin A, Derouet M, Abdel-Sater F, Hueber AO . (2009). Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling. Biochem J 419: 185–192.

    CAS  PubMed  Google Scholar 

  • Ryu BK, Lee MG, Chi SG, Kim YW, Park JH . (2001). Increased expression of cFLIP(L) in colonic adenocarcinoma. J Pathol 194: 15–19.

    CAS  PubMed  Google Scholar 

  • Said TM, Paasch U, Glander HJ, Agarwal A . (2004). Role of caspases in male infertility. Hum Reprod Update 10: 39–51.

    CAS  PubMed  Google Scholar 

  • Salvesen GS, Duckett CS . (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3: 401–410.

    CAS  PubMed  Google Scholar 

  • Sanchez Mejia RO, Friedlander RM . (2001). Caspases in Huntington's disease. Neuroscientist 7: 480–489.

    CAS  PubMed  Google Scholar 

  • Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675–1687.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T et al. (1997a). TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7: 831–836.

    CAS  PubMed  Google Scholar 

  • Schneider TJ, Grillot D, Foote LC, Nunez GE, Rothstein TL . (1997b). Bcl-x protects primary B cells against Fas-mediated apoptosis. J Immunol 159: 4834–4839.

    CAS  PubMed  Google Scholar 

  • Schneider-Brachert W, Tchikov V, Merkel O, Jakob M, Hallas C, Kruse ML et al. (2006). Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J Clin Invest 116: 2901–2913.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J et al. (2004). Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21: 415–428.

    CAS  PubMed  Google Scholar 

  • Schutze S, Tchikov V, Schneider-Brachert W . (2008). Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 9: 655–662.

    PubMed  Google Scholar 

  • Scorrano L . (2008). Caspase-8 goes cardiolipin: a new platform to provide mitochondria with microdomains of apoptotic signals? J Cell Biol 183: 579–581.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, Zella D et al. (2003). TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107: 2250–2256.

    PubMed  Google Scholar 

  • Sharp DA, Lawrence DA, Ashkenazi A . (2005). Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 280: 19401–19409.

    CAS  PubMed  Google Scholar 

  • Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA et al. (2007). Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104: 11400–11405.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D et al. (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818–821.

    CAS  PubMed  Google Scholar 

  • Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D et al. (2000). Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288: 2354–2357.

    CAS  PubMed  Google Scholar 

  • Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK . (2009). Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459: 428–432.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H . (2002). Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 21: 4520–4530.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J et al. (2000). FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12: 599–609.

    CAS  PubMed  Google Scholar 

  • Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J et al. (2001). A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112–116.

    CAS  PubMed  Google Scholar 

  • Strasser A, Harris AW, Huang DC, Krammer PH, Cory S . (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 6136–6147.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim HR, Lotan R et al. (2001). Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem Biophys Res Commun 280: 788–797.

    CAS  PubMed  Google Scholar 

  • Tafani M, Karpinich NO, Hurster KA, Pastorino JG, Schneider T, Russo MA et al. (2002). Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition. J Biol Chem 277: 10073–10082.

    CAS  PubMed  Google Scholar 

  • Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S et al. (2001). Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7: 94–100.

    CAS  PubMed  Google Scholar 

  • Tepper CG, Seldin MF . (1999). Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 94: 1727–1737.

    CAS  PubMed  Google Scholar 

  • Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517–521.

    CAS  PubMed  Google Scholar 

  • Thome M, Tschopp J . (2001). Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 1: 50–58.

    CAS  PubMed  Google Scholar 

  • van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P . (2002). The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9: 1031–1042.

    CAS  PubMed  Google Scholar 

  • Varfolomeev E, Alicke B, Elliott JM, Zobel K, West K, Wong H et al. (2009). X chromosome-linked inhibitor of apoptosis regulates cell death induction by proapoptotic receptor agonists. J Biol Chem 284: 34553–34560.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D et al. (2005). Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280: 40599–40608.

    CAS  PubMed  Google Scholar 

  • Varfolomeev E, Vucic D . (2008). (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle 7: 1511–1521.

    CAS  PubMed  Google Scholar 

  • Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL et al. (1998). Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267–276.

    CAS  PubMed  Google Scholar 

  • Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE et al. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43–53.

    CAS  PubMed  Google Scholar 

  • Vitovski S, Phillips JS, Sayers J, Croucher PI . (2007). Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways. J Biol Chem 282: 31601–31609.

    CAS  PubMed  Google Scholar 

  • Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M et al. (2008). Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Cancer Res 68: 7956–7965.

    CAS  PubMed  Google Scholar 

  • Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K et al. (2007). Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 13: 1070–1077.

    CAS  PubMed  Google Scholar 

  • Wandinger KP, Lunemann JD, Wengert O, Bellmann-Strobl J, Aktas O, Weber A et al. (2003). TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis. Lancet 361: 2036–2043.

    CAS  PubMed  Google Scholar 

  • Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ . (2001). Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 98: 13884–13888.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ . (1996). BID: a novel BH3 domain-only death agonist. Genes Dev 10: 2859–2869.

    CAS  PubMed  Google Scholar 

  • Wang X . (2001). The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922–2933.

    CAS  PubMed  Google Scholar 

  • Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001). Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727–730.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694–699.

    CAS  PubMed  Google Scholar 

  • Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673–682.

    CAS  PubMed  Google Scholar 

  • Wilson NS, Dixit V, Ashkenazi A . (2009). Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 10: 348–355.

    CAS  PubMed  Google Scholar 

  • Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS . (1999). Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 59: 2770–2775.

    CAS  PubMed  Google Scholar 

  • Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A et al. (2000). Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12: 633–642.

    CAS  PubMed  Google Scholar 

  • Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B et al. (1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886–891.

    CAS  PubMed  Google Scholar 

  • Yoshida T, Shiraishi T, Horinaka M, Wakada M, Sakai T . (2007). Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin. Oncol Rep 18: 1239–1242.

    CAS  PubMed  Google Scholar 

  • Youle RJ, Strasser A . (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47–59.

    CAS  PubMed  Google Scholar 

  • Yue HH, Diehl GE, Winoto A . (2005). Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice. Cell Death Differ 12: 94–97.

    CAS  PubMed  Google Scholar 

  • Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P . (2004). TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. Blood 104: 2044–2050.

    CAS  PubMed  Google Scholar 

  • Zauli G, Rimondi E, Stea S, Baruffaldi F, Stebel M, Zerbinati C et al. (2008). TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. J Cell Physiol 214: 117–125.

    CAS  PubMed  Google Scholar 

  • Zhang L, Ren X, Alt E, Bai X, Huang S, Xu Z et al. (2010). Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature 464: 1058–1061.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang XD, Borrow JM, Zhang XY, Nguyen T, Hersey P . (2003). Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Oncogene 22: 2869–2881.

    CAS  PubMed  Google Scholar 

  • Zhao X, Liu Y, Ma Q, Wang X, Jin H, Mehrpour M et al. (2009). Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells. Biochem Biophys Res Commun 378: 21–26.

    CAS  PubMed  Google Scholar 

  • Zheng SJ, Jiang J, Shen H, Chen YH . (2004). Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol 173: 5652–5658.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Oncology, Genentech Inc., South San Francisco, CA, USA

    F Gonzalvez & A Ashkenazi

Authors
  1. F Gonzalvez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Ashkenazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Ashkenazi.

Ethics declarations

Competing interests

The authors are full-time employees of Genentech, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonzalvez, F., Ashkenazi, A. New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29, 4752–4765 (2010). https://doi.org/10.1038/onc.2010.221

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.221

Keywords

This article is cited by

Search

Advanced search

Quick links